Sunday, May 10, 2026

"anti-diabetes-drug"

AstraZeneca gets marketing authorisation to use anti-diabetes drug for kidney disease

The study results of dapagliflozin showed significant benefits in reducing CKD progression in patients with and without type-2 diabetes.

Latest News

BRS chief KCR to chair key meeting at Erravelli on Tuesday

13 mins ago
Adopt work-from-home model: Modi urges austerity amid global tensions

25 mins ago
KTR extends Mother’s Day greetings

44 mins ago
Vijay’s debut as CM marked by ambitious schemes and immediate fiscal debate

58 mins ago
Bandi Sanjay dismisses POCSO case against son as political vendetta

1 hour ago
UPI toll payment gives breakthrough in Suvendu aide’s murder

1 hour ago
City boys’ world record in martial arts

1 hour ago
Udhayanidhi Stalin elected DMK legislature party leader

1 hour ago